Rottendorf Pharma GmbH is participating in a research project dedicated to a photodynamic tumor therapy. The “Medi-WING” promotion program is supported by the German Ministry of Education and Research (BMBF). Photostabilizers are a new and promising category of substances designed to enhance local effectiveness. The ingested photostabilizers are specifically activated through laser light to destroy cancer cells while minimizing damage to healthy cells.   Stefanie Krenzlin of Rottendorf Pharma, t...